MedTrace Logo

Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening

NCT00607425 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2008-07-17

No results posted yet for this study

Summary

This is a pilot study to test the feasibility of using gene expression from saliva to identify patients with early-stage non-small cell lung cancer (NSCLC).

The primary objective of this study is to compare gene expression profiles from saliva from healthy controls and patients with early-stage non-small cell lung cancer.

To be eligible, patients with non-small cell lung cancer, must not yet have received treatment for their cancer (surgical removal, chemotherapy, or radiation therapy). Health control participants may participate if they meet eligibility criteria listed below.

Eligible enrollees will be asked to submit a one time saliva sample and complete a study questionaire.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Glen J Weiss, MD · TGen Clinical Research Services at Scottsdale Healthcare

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00607425 on ClinicalTrials.gov